PCSA

PROCESSA PHARMACEUTICALS INC

PCSA·74275C205·US·Common Stock·Healthcare - Biotechnology

PCSA (PROCESSA PHARMACEUTICALS INC) is held by 8 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($42,412), CITADEL ADVISORS LLC ($40,908), XTX Topco Ltd ($25,521). Net institutional sentiment: Mixed.

8
Holders
$194,569
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
PCSA

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Aug 11, 2026 · Activists none · Congress none

InsiderNKNg George KExercise 2K shAug 8, 2026
InsiderYWYorke Justin WExercise 203 shJun 26, 2026
InsiderBKBaluch KhosoExercise 203 shJun 26, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
22,090(-11.3%)$42,4120.0%-31.46%
0
New
21,306$40,9080.0%-1.04%
31
New
13,292$25,5210.0%-1.04%
27
New
13,264$25,4660.0%-1.04%
29
Unchanged
12,729$24,4400.0%-24.60%
0
Unchanged
10,857$20,8450.0%-25.20%
0
Increased
7,794(+207.9%)$14,9640.0%-15.48%
20
Unchanged
7$130.0%-35.15%
0
Exited
0(-100.0%)$150.0%-34.47%
0
Exited
0(-100.0%)$350.0%-24.41%
0
PCSAPCSAPROCESSA PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used